Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04607291 · ClinicalTrials.gov registry record · Phase 1

Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening

A Phase 1 study, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
Phase 1
Development phase
183
Enrollment target

NCT04607291: Completed Phase 1 study, sponsored by Roswell Park Cancer Institute.

NCT04607291 is a Phase 1 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 183 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (205% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04607291, a Phase 1 study, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
Phase 1
Development phase
183 participants
Enrollment target

Study Summary

This phase I study investigates how well a health service program called Witness CARES Services works in increasing access and adherence to colorectal cancer screening in patients who have not undergone a colorectal screening in the past year. Providing patients with navigational and screening services via Witness CARES Services may improve access to and adherence levels of colorectal screening.

Primary Outcome

After CRC screening, satisfaction surveys will be conducted in order to assess the services of the Witness Cares Program. Below are responses to basic follow-up questions.

Interventions

  • OTHER Survey Administration
  • OTHER Community Health Service

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2019-09-01
Est. Completion 2021-05-14
Phase Phase 1
Roswell Park Cancer Institute

365 total trials

What the finished NCT04607291 record still lists

NCT04607291 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (205% higher).

The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.

NCT04607291 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04607291 about?

NCT04607291 is a clinical study titled "Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening". This phase I study investigates how well a health service program called Witness CARES Services works in increasing access and adherence to colorectal cancer screening in patients who have not undergone a colorectal screening in the past year. Providing patients with navigational and screening servi...

What is the current status of trial NCT04607291?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 183 participants. The study started on 2019-09-01. Estimated completion is 2021-05-14.

What interventions are being tested in trial NCT04607291?

The interventions under investigation include: Survey Administration (OTHER), Community Health Service (OTHER).

Who is sponsoring clinical trial NCT04607291?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04607291's enrollment target sits among peer trials

183 297th of 2000 higher than 1,702 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03859297 · 183 participants · NA

    Mechanisms of Rumination Change in Adolescent Depression

  • NCT04270591 · 183 participants · Phase 1

    Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

  • NCT06764615 · 183 participants · Phase 2

    A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • NCT06872684 · 183 participants · NA

    Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04607291, the US trial registry maintained by the National Library of Medicine. NCT04607291 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.